Senti Biosciences is trading 6.67% up at $0.32, though the immediate reason for the move is unclear.
- No clear company-specific catalyst was identified for September 16, 2026.
- Recent financing, merger, and potential contingent-value-right disclosures were announced earlier in September, not today.
- The broader Nasdaq was modestly higher, while biotechnology stocks were weaker.